Skip to main content

Search

Clear
Filter by Type
Filter by Topics
Filter by Symptoms & Conditions
Filter by Year
Counter Movement Jump (CMJ) - Achilles Tendinitis

Feb 2, 2014/Test & Measure

Measures strength and power of the gastrocnemius, soleus, and Achilles tendon complex; part of a test battery shown to be reliable and valid for evaluation of lower leg function in patients with Achilles tendinopathy.

Alberta Infant Motor Scale (AIMS)

Aug 28, 2017/Test & Measure

Assesses gross infant motor skills from ages 0 to 18 months.

Geriatric Depression Scale (GDS)

Jun 6, 2019/Test & Measure

Measures depression and suicidal ideation in elderly people.

Listen Up! Four Recent APTA Podcasts Worth Checking Out

Oct 30, 2023/Roundup

Learn about a landmark APTA report, explore APTA's new research agenda, share in one PT's professional journey, and more.

APTA Wins AMA Award for Education on Caregiver Training Codes

Apr 2, 2024/News

After helping create the CPT codes and advocate for their adoption, APTA launched an education campaign featuring a practice advisory.

CMS Listens to APTA, Eases Code Restrictions for Manual Therapy and Compression

Jan 5, 2022/News

APTA continues to advocate for changes that reflect the realities of physical therapy and patient-centered care.

President's Note | Choosing What Matters

Oct 1, 2026/Column

How we apply evidence, build partnerships, and invest in one another will shape the future of physical therapy.

Education Leadership Partnership

Dec 22, 2021/Article

The Education Leadership Partnership, a collaboration between APTA, ACAPT, and the Academy of Education, completed its charge with the published report "A Vision of Excellence in Physical Therapy Education."

Takeaways From the Proposed 2024 Medicare Physician Fee Schedule, Part 2

Jul 28, 2023/Article

MIPS reporting, value pathways, promoting interoperability, and more.

IMPROVE VTE Risk Model

Oct 31, 2021/Test & Measure

The IMPROVE VTE Risk Model is an assessment tool that is used to discriminate risk of developing validated venous thromboembolism (VTE) in patients who are critically ill, based on clinical variables.1